Accession Number: | 0001209191-21-039237 |
Date: | 2021-06-02 |
Issuer: | PMV PHARMACEUTICALS, INC. (PMVP) |
Original Submission Date: |
HEYMAN RICHARD A.
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY, NJ 08512
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 32.29 | 2021-06-02 | deemed execution date | A | 16,333 (a) | 2031-06-01 | common stock 16,333 | $32.29 | 16,333 | direct |
ID | footnote |
---|---|
f1 | shares subject to the option vest on the earlier of (i) june 2, 2022 or (ii) the day prior to the date of the issuer's next annual meeting of stockholders. |